|
ZNF415 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.616300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.355010E-03 |
| Normal-vs-Stage2 |
3.444200E-01 |
| Normal-vs-Stage3 |
7.63200000000186E-05 |
| Normal-vs-Stage4 |
3.04480000001828E-06 |
| Stage1-vs-Stage2 |
6.748100E-02 |
| Stage1-vs-Stage3 |
7.486100E-02 |
| Stage1-vs-Stage4 |
2.118600E-03 |
| Stage2-vs-Stage3 |
5.082300E-03 |
| Stage2-vs-Stage4 |
4.579600E-04 |
| Stage3-vs-Stage4 |
2.418600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.49419999999168E-05 |
| Normal-vs-AfricanAmerican |
7.711500E-02 |
| Normal-vs-Asian |
1.528470E-02 |
| Caucasian-vs-AfricanAmerican |
3.939600E-01 |
| Caucasian-vs-Asian |
3.007800E-01 |
| AfricanAmerican-vs-Asian |
9.317200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.496400E-03 |
| Normal-vs-Female |
1.378400E-04 |
| Male-vs-Female |
5.395800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.255870E-03 |
| Normal-vs-Age(41-60Yrs) |
7.248500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.143190E-03 |
| Normal-vs-Age(81-100Yrs) |
3.155800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.708000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.423000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.085000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.405000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.728400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.567800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.564400E-04 |
| Classical-VS-Follicular |
1.638080E-03 |
| Classical-VS-Other |
7.206000E-01 |
| Classical-VS-Normal |
8.799900E-04 |
| Tall-VS-Follicular |
1.20299999961659E-07 |
| Tall-VS-Other |
1.487610E-01 |
| Tall-VS-Normal |
1.9850999999349E-07 |
| Follicular-VS-Other |
2.569600E-02 |
| Follicular-VS-Normal |
5.083600E-01 |
| Other-VS-Normal |
1.009990E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.563700E-03 |
| Normal-vs-N1 |
3.71700000000308E-05 |
| N0-vs-N1 |
1.483520E-02 |
|
|
